These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 20011881)

  • 1. Topical use of antifibrinolytic agent to reduce postoperative bleeding after coronary artery bypass surgery.
    Breda JR; Gurian DB; Breda AS; Meneghine A; Freitas AC; Matos LL; Abreu LC; Pires AC
    Rev Bras Cir Cardiovasc; 2009; 24(3):341-5. PubMed ID: 20011881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical use of antifibrinolytic agents reduces postoperative bleeding: a double-blind, prospective, randomized study.
    Baric D; Biocina B; Unic D; Sutlic Z; Rudez I; Vrca VB; Brkic K; Ivkovic M
    Eur J Cardiothorac Surg; 2007 Mar; 31(3):366-71; discussion 371. PubMed ID: 17218108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized trial of the topical effect of antifibrinolytic epsilon aminocaproic Acid on coronary artery bypass surgery without cardiopulmonary bypass.
    Gurian DB; Meneghini A; Abreu LC; Murad N; Matos LL; Pires AC; Valenti VE; Breda JR
    Clin Appl Thromb Hemost; 2014 Sep; 20(6):615-20. PubMed ID: 23434921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraoperative antifibrinolysis and blood-saving techniques in cardiac surgery. Prospective trial of 3 antifibrinolytic drugs.
    Penta de Peppo A; Pierri MD; Scafuri A; De Paulis R; Colantuono G; Caprara E; Tomai F; Chiariello L
    Tex Heart Inst J; 1995; 22(3):231-6. PubMed ID: 7580360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of epsilon-aminocaproic acid on fibrinolysis and thrombin generation during cardiac surgery.
    Slaughter TF; Faghih F; Greenberg CS; Leslie JB; Sladen RN
    Anesth Analg; 1997 Dec; 85(6):1221-6. PubMed ID: 9390584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postoperatively administered aprotinin or epsilon aminocaproic acid after cardiopulmonary bypass has limited benefit.
    Ray MJ; Hales MM; Brown L; O'Brien MF; Stafford EG
    Ann Thorac Surg; 2001 Aug; 72(2):521-6. PubMed ID: 11515892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tranexamic acid reduces bleeding after cardiopulmonary bypass when compared to epsilon aminocaproic acid and placebo.
    Pinosky ML; Kennedy DJ; Fishman RL; Reeves ST; Alpert CC; Ecklund J; Kribbs S; Spinale FG; Kratz JM; Crawford R; Gravlee GP; Dorman BH
    J Card Surg; 1997; 12(5):330-8. PubMed ID: 9635271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epsilon aminocaproic acid reduces blood transfusion and improves the coagulation test after pediatric open-heart surgery: a meta-analysis of 5 clinical trials.
    Lu J; Meng H; Meng Z; Sun Y; Pribis JP; Zhu C; Li Q
    Int J Clin Exp Pathol; 2015; 8(7):7978-87. PubMed ID: 26339364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of epsilon aminocaproic acid on red-cell transfusion requirements in major spinal surgery.
    Berenholtz SM; Pham JC; Garrett-Mayer E; Atchison CW; Kostuik JP; Cohen DB; Nundy S; Dorman T; Ness PM; Klag MJ; Pronovost PJ; Kebaish KM
    Spine (Phila Pa 1976); 2009 Sep; 34(19):2096-103. PubMed ID: 19730217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of epsilon aminocaproic acid and tranexamic Acid in thoracic aortic surgery: clinical efficacy and safety.
    Makhija N; Sarupria A; Kumar Choudhary S; Das S; Lakshmy R; Kiran U
    J Cardiothorac Vasc Anesth; 2013 Dec; 27(6):1201-7. PubMed ID: 24050855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Intravenous Aminocaproid Acid on Blood Loss and Transfusion Requirements After Bilateral Varus Rotational Osteotomy: A Double-blind, Placebo-controlled Randomized Trial.
    Swarup I; Nguyen J; Edmonds C; Dodwell E; Scher D
    J Pediatr Orthop; 2020 Jul; 40(6):e454-e459. PubMed ID: 32501914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of antifibrinolytic agents on surgical bleeding and transfusion requirements in spine surgery: a meta-analysis.
    Li G; Sun TW; Luo G; Zhang C
    Eur Spine J; 2017 Jan; 26(1):140-154. PubMed ID: 27671279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of low-dose epsilon-aminocaproic acid on patients following coronary artery bypass surgery.
    Montesano RM; Gustafson PA; Palanzo DA; Manley NJ; Sadr FS
    Perfusion; 1996 Jan; 11(1):53-6. PubMed ID: 8904327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association of epsilon-aminocaproic acid with postoperative decrease in creatinine clearance in 1502 coronary bypass patients.
    Stafford-Smith M; Phillips-Bute B; Reddan DN; Black J; Newman MF
    Anesth Analg; 2000 Nov; 91(5):1085-90. PubMed ID: 11049888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epsilon Aminocaproic Acid to Reduce Blood Loss and Transfusion After Total Hip and Total Knee Arthroplasty.
    Hobbs JC; Welsby IJ; Green CL; Dhakal IB; Wellman SS
    J Arthroplasty; 2018 Jan; 33(1):55-60. PubMed ID: 28939033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of epsilon-aminocaproic acid and aprotinin on fibrinolysis and blood loss in patients undergoing primary, isolated coronary artery bypass surgery: a randomized, double-blind, placebo-controlled, noninferiority trial.
    Greilich PE; Jessen ME; Satyanarayana N; Whitten CW; Nuttall GA; Beckham JM; Wall MH; Butterworth JF
    Anesth Analg; 2009 Jul; 109(1):15-24. PubMed ID: 19535691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tranexamic acid versus aminocapróic acid in multiple doses via the oral route for the reduction of postoperative bleeding in total primary hip arthroplasty: a prospective, randomized, double-blind, controlled study.
    Morales-Avalos R; Ramos-Morales T; García-Pedro JA; Espinoza-Galindo AM; Acosta-Olivo C; Morcos-Sandino M; Silva-Ramos HNG; Peña-Martínez VM; Rodríguez-Torres RA; Vilchez-Cavazos F
    Blood Coagul Fibrinolysis; 2021 Mar; 32(2):132-139. PubMed ID: 33443925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epsilon-aminocaproic acid influence in postoperative [corrected] bleeding and hemotransfusion [corrected] in mitral valve surgery.
    Benfatti RÁ; Carli AF; Silva GV; Dias AE; Goldiano JA; Pontes JC
    Rev Bras Cir Cardiovasc; 2010; 25(4):510-5. PubMed ID: 21340381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of prophylactic epsilon-aminocaproic acid on bleeding, transfusions, platelet function, and fibrinolysis during coronary artery bypass grafting.
    Troianos CA; Sypula RW; Lucas DM; D'Amico F; Mathie TB; Desai M; Pasqual RT; Pellegrini RV; Newfeld ML
    Anesthesiology; 1999 Aug; 91(2):430-5. PubMed ID: 10443606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind, placebo-controlled trial of epsilon-aminocaproic acid for reducing blood loss in coronary artery bypass grafting surgery.
    Kikura M; Levy JH; Tanaka KA; Ramsay JG
    J Am Coll Surg; 2006 Feb; 202(2):216-22; quiz A44-5. PubMed ID: 16427545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.